维普中文期刊产品整合服务
8篇 您的检索式:作者名="Lowenstein MB"
    题名 作者 年代 出处 被引量
1Ocrelizumab,a humanized anti-CD20 monoclonal antibody,in the treatment of patients with rheumatoid arthritis:A phase Ⅰ/Ⅱ randomized,blinded,placebo-controlled,dose-ranging study显示文摘Genovese MC Kaine JL Lowenstein MB 0,,:1
2Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I/II randomized, blinded, placebo-controlled, dose-ranging study显示文摘GENOVESE MC KAINE JL LOWENSTEIN MB 2008Arthritis Rheum2008,58,9:1
3Psycho-social factors affecting elders' maltreatment in long-term care facilities显示文摘Natan MB Lowenstein A Eisikovits Z 0,,01:1
4Psycho-social factors affecting elders' maltreatment in long-term care facilities显示文摘Natan MB Lowenstein A Eisikovits Z 0,,1:1
5Oerolizumab, a humanized anti-CD20 monoelonal antibody, in the treatment of pa- tients with rheumatoid arthritis: a phase I/11 randomized, blinded, placebo-controlled, dose-ranging study 显示文摘Genovese MC Kaine JL Lowenstein MB 2008Arthritis Rheum2008,58,9:1
6Ocrelizumab,a humanized anti-CD20 monoclonal antibody,in the treatment of patients with rheumatoid arthritis:a phase Ⅰ/Ⅱ randomized,blinded,placebo-controlled,dose-ranging study显示文摘Genovese MC Kaine JL Lowenstein MB 2008Arthritis Rheum2008,58,9:1
7Psycho-social Factors Affecting Eiders' Maltreatment in Long-term Care Facilities显示文摘Natan MB Lowenstein A Eisikovits Z 2010Int Nuts Rev2010,57,1:1
8Oerelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I/II randomized, blinded, placebo-controlled, dose-ranging study 显示文摘GENOESE MC KAINE JL LOWENSTEIN MB 2008Arthritis Rheum2008,58,9:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费